eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0003864|arthritis |
| Sentences | 23 |
| PubMedID- 22029973 | Introduction: calprotectin (mrp8/mrp14, s100a8/a9) is associated with disease activity in patients with rheumatoid arthritis (ra). |
| PubMedID- 24839407 | Seven of nine patients had systemic symptoms, and eight had active, uninterrupted arthritis with disease duration of 23–144 months. |
| PubMedID- 23983001 | Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. |
| PubMedID- 22403639 | Illustrating this, we recently found, in women with rheumatoid arthritis, fluctuating levels of mc coinciding with disease flare up and treatment [34]. |
| PubMedID- 25889060 | Introduction: a higher prevalence of metabolic syndrome (mets) has been described in rheumatoid arthritis (ra), along with an association with disease activity. |
| PubMedID- 25995670 | This correlation of hip arthritis with disease progression in as may result from the fact that the hip joints are anatomically closer to the axial skeleton. |
| PubMedID- 24057092 | Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity. |
| PubMedID- 22242205 | The current treatment approach for patients with rheumatoid arthritis involves early initiation of aggressive therapy with disease-modifying drugs (dmards) and biologic agents. |
| PubMedID- 20236522 | Barriers to care [1-5] continue to suppress the therapeutic advantages of early pharmacological intervention in inflammatory arthritis (ia) with disease-modifying anti-rheumatic drugs (dmards) [6-8]. |
| PubMedID- 26028977 | In 1977, steere et al3 described a syndrome including tick bites, a rash termed at that time erythema chronicum migrans (now erythema migrans, em), nonspecific symptoms including headache, malaise, fatigue, myalgias, and fever, and recurrent episodes of frank arthritis, with disease duration of up to 22 weeks. |
| PubMedID- 24658637 | Etanercept for psoriasis and psoriatic arthritis in a patient with charcot-marie-tooth disease. |
| PubMedID- 25458025 | Objectives: this study aims to investigate the relationship of hemoglobin level with disease activity in patients with rheumatoid arthritis (ra). |
| PubMedID- 24151615 | Periodontal disease was found to be highly associated with other chronic inflammatory diseases such as cardiovascular disease, metabolic syndrome, diabetes, and rheumatoid arthritis increasing the risk of developing such diseases [3–6]. |
| PubMedID- 21303509 | The present study is aimed at assessing fstl1 levels in systemic autoimmune diseases and correlating them with disease activity in patients with rheumatoid arthritis (ra). |
| PubMedID- 25889527 | Treating rheumatoid arthritis (ra) with disease modifying anti-rheumatic drugs (dmards) according to a treat-to-target (t2t) strategy is more effective than traditional routine care [1-5]. |
| PubMedID- 26064964 | The objective of this study is to examine and evaluate whether serum 25(oh)d is associated with disease activity in patients with rheumatoid arthritis (ra). |
| PubMedID- 21276257 | These subjects were 13-15 years old, 2 had polyarticular and 1 oligoarticular arthritis, with disease duration of 6, 102, and 129 months, respectively. |
| PubMedID- 20158894 | Associations of endothelial progenitor cell (epc) levels in rheumatoid arthritis (ra) with disease activity. |
| PubMedID- 20881757 | Objectives: (1) to determine 6-month follow-up adherence and persistence with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis with disease under control. |
| PubMedID- 21679442 | Conclusions: these findings indicate that ifn-lambda1 is probably involved in the renal disorder and arthritis progression of sle and associated with disease activity. |
| PubMedID- 26064129 | Definitive treatment for rheumatoid arthritis begins with disease-modifying antirheumatic drugs (dmards) such as methotrexate (mtx). |
| PubMedID- 26087054 | Aim: to investigate the presence of autoantibodies (aabs) against interleukin (il)-17a and il-17f and observe whether anti-il-17a or il-17f aabs are associated with disease activity in patients with early rheumatoid arthritis (era). |
| PubMedID- 20032101 | Objective: to assess whether serum levels of cc and cxc chemokines correlate with disease activity in patients with rheumatoid arthritis (ra), and to determine whether these effects predict clinical response. |
Page: 1